Software Refraction With Mobilerone Versus Retinoscopy

Launched by BEIJING AIRDOC TECHNOLOGY CO., LTD. · Sep 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new device called Mobilerone, which helps measure vision to treat conditions like myopia (nearsightedness) and astigmatism in adults and older children. The researchers want to find out how accurate and safe this device is compared to traditional eye tests. If you or someone you know has trouble seeing clearly, especially with myopia or astigmatism, this trial might be of interest.

To participate, you should be between the ages of 1 and 46 years and have specific vision issues, such as myopia that's worse than -12.00 diopters (a measure of how nearsighted you are). You also need to have good vision with correction, no serious eye problems, and no recent eye surgeries. Participants will have their vision tested using the Mobilerone device and will be closely monitored for safety throughout the study. This trial is currently looking for volunteers, and all genders are welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • subject with ametropia on each eye ≤-12.00D
• • subject with best corrected visual acuity ≥ 20/25, no amblyopia
• • subject with normal transparency of eyes
• • subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
• • subject able to cooperate with the screen and the operator
• • subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
• • non-diabetic subject
• • non nystagmus subject
• • non-strabismus subject
• • subject who has not had eye surgery less than 1 year old
• Exclusion Criteria:
• • • subject with a topography showing an anomaly (keratoconus type or other)
• • subject with hyperopia or presbyopia
• • subject with mild myopia ≥ -1.00D
• • subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists